Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationCocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA inductionCannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosisHigh tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.Increased expression of cannabinoid CB₁ receptors in Achilles tendinosis.Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoidsInhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in miceModulating the endocannabinoid system in human health and disease--successes and failuresTherapeutic Use of Cannabis in Inflammatory Bowel Disease.IBD: Patients with IBD find symptom relief in the Cannabis field.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.The Role of the Endocannabinoid System in the Brain-Gut Axis.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Endocannabinoids in the gastrointestinal tract.The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling.Cannabis finds its way into treatment of Crohn's disease.Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).Distribution and function of the endocannabinoid system in the rat and human bladder.Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Endocannabinoid-related compounds in gastrointestinal diseases.Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.
P2860
Q24633122-23E92412-CFAB-48E6-8142-B1A2E4B7CA3AQ26824588-59575CF3-E11A-48AA-B7D4-E5EE41864F2CQ30357558-7F5A31D6-0EBD-46D7-9778-0CEC069D96FEQ30630783-421CFFF6-7C30-425F-95F8-A6D539AD75FDQ31156796-541B5C91-F2B3-464C-B807-5D5F176BED37Q33984006-84FD32CF-CF7E-4D9E-9C3F-3D4D559804AAQ34013690-9E59B22C-8F2A-4556-8B5E-018742EF5EE4Q34023999-05E13E5C-8E35-447B-A3D1-6AF48D7B53E3Q34145142-8EB9C3EF-63AC-431F-B579-CC63D8256288Q34291196-11759F22-BF5F-4F15-AE36-075211380FC5Q35693020-BF9CB113-5757-48F0-B0D6-FAE64BCE73DAQ36024979-DCA5BE32-91DC-409C-AEAF-D373C4DFC43FQ36890194-724B2D1C-0F13-4796-9E3A-7BEBB26D4EE9Q36933683-B71152DD-A0D7-447F-9960-6444603C3810Q37540208-3148ABA6-9658-4B8D-B0ED-BCE199150841Q37627086-9462BA20-411B-4DAD-9016-BF45141F9CEDQ37960078-F1ACF546-14F2-43FE-88B6-EF6FDB3E2DB0Q38599291-9EAEFD34-C0D3-474C-BDFC-785AAA5842BAQ38761437-21F955F9-E129-42B5-95C6-6387182D3253Q38822341-2C8AF9F1-1B16-436E-A74A-768628EF4FF2Q38918638-65D15D46-BBB5-43CC-AD5E-91C66042081EQ38931168-75742ACD-EF22-4AED-B17F-108562A56B1CQ38937293-1973C7C8-4240-4CF5-8F27-35050BF6042AQ39248070-F556D7AD-EE10-4458-BA7E-6FD89370E344Q40997924-0B9D2F67-AC0E-496C-B896-BD919214A400Q41542729-078A6460-389A-4CA8-B125-804C54AFAAF0Q41778849-8F479124-3FC7-4842-BB1B-FB1BE579970CQ42012570-DFD6E96A-F9C1-4838-B65A-9B28781E7D9BQ44984018-3F09F93D-5BD5-42C0-B8ED-5D667D2BE10EQ45288114-EFF5F162-A450-429B-B3A4-7584D1DACECEQ47839554-81FD8C7A-5026-471E-881F-B051850FEA80Q55090140-0E1F2FA4-6EAF-46F7-963D-D9F40752FB4E
P2860
Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ulcerative colitis induces cha ...... em in the human colonic tissue
@ast
Ulcerative colitis induces cha ...... em in the human colonic tissue
@en
Ulcerative colitis induces cha ...... em in the human colonic tissue
@nl
type
label
Ulcerative colitis induces cha ...... em in the human colonic tissue
@ast
Ulcerative colitis induces cha ...... em in the human colonic tissue
@en
Ulcerative colitis induces cha ...... em in the human colonic tissue
@nl
prefLabel
Ulcerative colitis induces cha ...... em in the human colonic tissue
@ast
Ulcerative colitis induces cha ...... em in the human colonic tissue
@en
Ulcerative colitis induces cha ...... em in the human colonic tissue
@nl
P2093
P2860
P1433
P1476
Ulcerative colitis induces cha ...... em in the human colonic tissue
@en
P2093
Fernando Rodríguez de Fonseca
Francisco Javier Bermudez-Silva
Juan Suárez
Lucia Marquéz
Mar Iglesias
Montserrat Andreu
P2860
P356
10.1371/JOURNAL.PONE.0006893
P407
P577
2009-01-01T00:00:00Z